FDA approves rusfertide (Mimrylo), a first-in-class hepcidin mimetic that regulates iron to control erythrocytosis in ...

FDA approves BESREMi (ropeginterferon alfa-2b-njft) as the first new treatment option for essential thrombocythemia in nearly ...

Oncology nurses share high-level strategies for advanced RCC therapy, focusing on managing hypertension, diarrhea, and ...

Surbhi Sidana, MD, discusses how the FDA-approved oral CELMoD iberdomide expands access and impacts nursing care in multiple ...

C, of Banner MD Anderson Cancer Center at Banner Gateway Medical Center, reviews the venous thromboembolism (VTE) data behind ...

A new study shows physical activity increases tumor-killing T cells and reduces suppressive Tregs in obese lung environments, ...

Having recently moderated a case-based roundtable discussion on triple-negative breast cancer, Iorio shares her clinical ...

Sarah Cannon's Kelsey Martin, APRN, AOCNP, discusses managing toxicities, nursing collaboration, and tailored treatment sequencing in frontline mTNBC. In an era of rapid oncology advancements, ...

C, discussed the collaborative care model and the vital role of PAs in managing day-to-day oncology care. Physician ...

FDA approves daraxonrasib, a first-in-class daily oral RAS inhibitor, doubling survival in metastatic pancreatic ...

Emily Beard discusses how nurse navigators act as essential bridges, leveraging clinical intuition and time to address ...

Christine Magnus Moore, RN, BSN, CPON has worked in the nursing field for over twenty-five years, with more than fourteen years in oncology. She has a Master’s Certification in caring for teenagers ...